Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo
Authors
Keywords
-
Journal
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
Volume 99B, Issue 1, Pages 70-80
Publisher
Wiley
Online
2011-06-08
DOI
10.1002/jbm.b.31873
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galactosylated chitosan-g-PEI/DNA complexes-loaded poly(organophosphazene) hydrogel as a hepatocyte targeting gene delivery system
- (2010) Hu-Lin Jiang et al. ARCHIVES OF PHARMACAL RESEARCH
- Polymeric Carriers for Gene Delivery: Chitosan and Poly(amidoamine) Dendrimers
- (2010) Qingxing Xu et al. CURRENT PHARMACEUTICAL DESIGN
- Biocompatible Nanoparticles Intercalated with Anticancer Drug for Target Delivery: Pharmacokinetic and Biodistribution Study
- (2010) Soo-Jin Choi et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Summary Statement Novel Agents in the Treatment of Lung Cancer: Fifth Cambridge Conference Assessing Opportunities for Combination Therapy
- (2010) Thomas J. Lynch et al. Journal of Thoracic Oncology
- Immunoliposomal systems targeting primary effusion lymphoma:in vitrostudy
- (2010) Barbara Ruozi et al. Nanomedicine
- Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: anin vitroevaluation
- (2010) Wei Wei et al. Nanomedicine
- Targeting Liposomes Toward Novel Pediatric Anticancer Therapeutics
- (2010) Noah Federman et al. PEDIATRIC RESEARCH
- Chitosan-based formulations for delivery of DNA and siRNA
- (2009) Shirui Mao et al. ADVANCED DRUG DELIVERY REVIEWS
- Progress and Prospects of Chitosan and Its Derivatives as Non-Viral Gene Vectors in Gene Therapy
- (2009) Haijun Tong et al. CURRENT GENE THERAPY
- Saccharide Modified Pharmaceutical Nanocarriers for Targeted Drug and Gene Delivery
- (2009) Wangyang Yu et al. CURRENT PHARMACEUTICAL DESIGN
- Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon
- (2009) Xia Wang et al. HEPATOLOGY
- Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model
- (2009) Jun Dou et al. IMMUNOBIOLOGY
- Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice
- (2009) Fengshu Zhao et al. IMMUNOBIOLOGY
- Glycated chitosan as a new non-toxic immunological stimulant
- (2009) Sheng Song et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Synthesis and evaluation of chitosan-Vitamin C complex
- (2009) FK Mo et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Semiquantitative Study of the EDC/NHS Activation of Acid Terminal Groups at Modified Porous Silicon Surfaces
- (2009) S. Sam et al. LANGMUIR
- Biological Gene Delivery Vehicles: Beyond Viral Vectors
- (2009) Yiqi Seow et al. MOLECULAR THERAPY
- Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles
- (2008) Guifang Huang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes
- (2008) Emilie Letrou-Bonneval et al. JOURNAL OF GENE MEDICINE
- Targeted Delivery of Macromolecular Drugs: Asialoglycoprotein Receptor (ASGPR) Expression by Selected Hepatoma Cell Lines used in Antiviral Drug Development
- (2008) Yan Li et al. Current Drug Delivery
- Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytesin vivo
- (2007) Lei Dong et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More